Mathematics
Cancer
100%
Tumor
65%
Rare Events
61%
Importance Sampling
59%
Drug Resistance
53%
Cell
44%
Mutant
41%
Timing
40%
Mutation
40%
Therapy
39%
Resistance
35%
Recurrence
34%
Drugs
32%
Large Deviations
27%
Queue
26%
Spatial Model
26%
Schedule
24%
Recurrence Equations
23%
Leukemia
23%
Fitness
22%
Subsolution
22%
Rare Event Simulation
21%
Clone
21%
Radiation
21%
Model
20%
Carcinogenesis
20%
Stochastic Equations
18%
Phenotype
17%
Simulation
14%
Colorectal Cancer
14%
Asymptotically Optimal
14%
Reflecting Brownian Motion
13%
Policy
13%
Cell Proliferation
13%
Irradiation
12%
Lyapunov Inequality
12%
Efficient Estimation
12%
Wishart Matrix
12%
Sums of Random Variables
12%
Radiotherapy
12%
Driver
11%
Stochastic Modeling
11%
Multi-class
11%
Rate Function
11%
Single Server
11%
Progression
11%
Medicine & Life Sciences
Neoplasms
59%
Appointments and Schedules
42%
Drug Resistance
35%
Glioblastoma
27%
Radiotherapy
26%
Radiation
26%
Recurrence
21%
Preclinical Drug Evaluations
21%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
21%
Protein-Tyrosine Kinases
20%
Epigenomics
19%
Uncertainty
18%
Phenotype
16%
Pharmaceutical Preparations
16%
Therapeutics
15%
Theoretical Models
14%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
14%
Mutation
14%
Carcinogenesis
12%
O-(6)-methylguanine
12%
Growth
11%
Temozolomide
11%
Non-Small Cell Lung Carcinoma
10%
Genetic Heterogeneity
10%
Population
10%
Methyltransferases
10%
Neoplastic Stem Cells
9%
Head and Neck Neoplasms
9%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8%
Tobacco
8%
Radiosurgery
8%
Cell Division
8%
Methylation
8%
Imatinib Mesylate
7%
Colorectal Neoplasms
7%
Population Dynamics
7%
Phosphotransferases
7%
Clone Cells
6%
Cell Proliferation
6%
Mutation Accumulation
6%
Kinetics
6%
Parturition
6%
Tumor Burden
6%
Brain Neoplasms
6%
Treatment Failure
6%
Drug Therapy
5%
Organs at Risk
5%
Mutation Rate
5%
Cell Death
5%
Survival
5%
Agriculture & Biology
neoplasms
87%
therapeutics
36%
drug resistance
35%
myeloid leukemia
26%
mutation
24%
epigenetics
21%
drugs
17%
carcinogenesis
17%
cells
17%
phenotype
15%
neoplasm progression
15%
statistical inference
13%
glioblastoma
13%
neoplasm cells
12%
lymphocytic leukemia
12%
radiotherapy
12%
phosphotransferases (kinases)
11%
colorectal neoplasms
11%
tissues
10%
mathematical models
9%
stem cells
9%
mutation accumulation
8%
mutation rate
8%
cell proliferation
8%
plasticity
8%
drug therapy
7%
dosage
7%
image analysis
7%
tyrosine
7%
kinetics
7%
death
7%
screening
6%
resistance mechanisms
6%
clones
5%
cell death
5%
branching
5%